Triple-negative breast cancer (TNBC) is a special subtype of breast cancer that lacks an estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and has worse prognosis than other breast cancer subtypes [1–3]. This evidence concerns the gene PGR and breast cancer.